Cargando…
Timosaponin AIII Induces G2/M Arrest and Apoptosis in Breast Cancer by Activating the ATM/Chk2 and p38 MAPK Signaling Pathways
Timosaponin AIII (TAIII), a steroidal saponin, exerts potent anti-tumor activity in various cancers, especially breast cancer. However, the concrete molecular mechanisms of TAIII against breast cancer are still unclear. Here, we find that TAIII triggers DNA damage, leads to G2/M arrest, and ultimate...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898553/ https://www.ncbi.nlm.nih.gov/pubmed/33628174 http://dx.doi.org/10.3389/fphar.2020.601468 |
_version_ | 1783653884697247744 |
---|---|
author | Zhang, Minjie Qu, Jiaxi Gao, Zhiwei Qi, Qi Yin, Hong Zhu, Ling Wu, Yichen Liu, Wei Yang, Jian Huang, Xuefeng |
author_facet | Zhang, Minjie Qu, Jiaxi Gao, Zhiwei Qi, Qi Yin, Hong Zhu, Ling Wu, Yichen Liu, Wei Yang, Jian Huang, Xuefeng |
author_sort | Zhang, Minjie |
collection | PubMed |
description | Timosaponin AIII (TAIII), a steroidal saponin, exerts potent anti-tumor activity in various cancers, especially breast cancer. However, the concrete molecular mechanisms of TAIII against breast cancer are still unclear. Here, we find that TAIII triggers DNA damage, leads to G2/M arrest, and ultimately induces apoptosis in breast cancer both in vitro and in vivo. TAIII induced G2/M phase arrest and apoptosis in MDA-MB-231 and MCF7 cells accompanied with down-regulation of CyclinB1, Cdc2 and Cdc25C. Further data showed that the ATM/Chk2 and p38 pathways were activated representing by up-regulated levels of p-H2A.X and p-p38, which indicated an induction of DNA damage by TAIII, leading to cell cycle arrest and apoptosis. The effects of TAIII were further confirmed by employing inhibitors of ATM and p38 pathways. In vivo, TAIII suppressed the growth of subcutaneous xenograft tumor without obvious toxicity, which indicated by Ki67 and TUNEL analysis. Data also showed that TAIII stimulated the ATM/Chk2 and p38 MAPK pathways in vivo, which in consistent with the effects in vitro. Hence, our data demonstrate that TAIII triggers DNA damage and activates ATM/Chk2 and p38 MAPK pathways, and then induces G2/M phase arrest and apoptosis in breast cancer, which provide theoretical evidence for TAIII utilized as drug against breast cancer. |
format | Online Article Text |
id | pubmed-7898553 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78985532021-02-23 Timosaponin AIII Induces G2/M Arrest and Apoptosis in Breast Cancer by Activating the ATM/Chk2 and p38 MAPK Signaling Pathways Zhang, Minjie Qu, Jiaxi Gao, Zhiwei Qi, Qi Yin, Hong Zhu, Ling Wu, Yichen Liu, Wei Yang, Jian Huang, Xuefeng Front Pharmacol Pharmacology Timosaponin AIII (TAIII), a steroidal saponin, exerts potent anti-tumor activity in various cancers, especially breast cancer. However, the concrete molecular mechanisms of TAIII against breast cancer are still unclear. Here, we find that TAIII triggers DNA damage, leads to G2/M arrest, and ultimately induces apoptosis in breast cancer both in vitro and in vivo. TAIII induced G2/M phase arrest and apoptosis in MDA-MB-231 and MCF7 cells accompanied with down-regulation of CyclinB1, Cdc2 and Cdc25C. Further data showed that the ATM/Chk2 and p38 pathways were activated representing by up-regulated levels of p-H2A.X and p-p38, which indicated an induction of DNA damage by TAIII, leading to cell cycle arrest and apoptosis. The effects of TAIII were further confirmed by employing inhibitors of ATM and p38 pathways. In vivo, TAIII suppressed the growth of subcutaneous xenograft tumor without obvious toxicity, which indicated by Ki67 and TUNEL analysis. Data also showed that TAIII stimulated the ATM/Chk2 and p38 MAPK pathways in vivo, which in consistent with the effects in vitro. Hence, our data demonstrate that TAIII triggers DNA damage and activates ATM/Chk2 and p38 MAPK pathways, and then induces G2/M phase arrest and apoptosis in breast cancer, which provide theoretical evidence for TAIII utilized as drug against breast cancer. Frontiers Media S.A. 2021-01-15 /pmc/articles/PMC7898553/ /pubmed/33628174 http://dx.doi.org/10.3389/fphar.2020.601468 Text en Copyright © 2021 Zhang, Qu, Gao, Qi, Yin, Zhu, Wu, Liu, Yang and Huang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Zhang, Minjie Qu, Jiaxi Gao, Zhiwei Qi, Qi Yin, Hong Zhu, Ling Wu, Yichen Liu, Wei Yang, Jian Huang, Xuefeng Timosaponin AIII Induces G2/M Arrest and Apoptosis in Breast Cancer by Activating the ATM/Chk2 and p38 MAPK Signaling Pathways |
title | Timosaponin AIII Induces G2/M Arrest and Apoptosis in Breast Cancer by Activating the ATM/Chk2 and p38 MAPK Signaling Pathways |
title_full | Timosaponin AIII Induces G2/M Arrest and Apoptosis in Breast Cancer by Activating the ATM/Chk2 and p38 MAPK Signaling Pathways |
title_fullStr | Timosaponin AIII Induces G2/M Arrest and Apoptosis in Breast Cancer by Activating the ATM/Chk2 and p38 MAPK Signaling Pathways |
title_full_unstemmed | Timosaponin AIII Induces G2/M Arrest and Apoptosis in Breast Cancer by Activating the ATM/Chk2 and p38 MAPK Signaling Pathways |
title_short | Timosaponin AIII Induces G2/M Arrest and Apoptosis in Breast Cancer by Activating the ATM/Chk2 and p38 MAPK Signaling Pathways |
title_sort | timosaponin aiii induces g2/m arrest and apoptosis in breast cancer by activating the atm/chk2 and p38 mapk signaling pathways |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898553/ https://www.ncbi.nlm.nih.gov/pubmed/33628174 http://dx.doi.org/10.3389/fphar.2020.601468 |
work_keys_str_mv | AT zhangminjie timosaponinaiiiinducesg2marrestandapoptosisinbreastcancerbyactivatingtheatmchk2andp38mapksignalingpathways AT qujiaxi timosaponinaiiiinducesg2marrestandapoptosisinbreastcancerbyactivatingtheatmchk2andp38mapksignalingpathways AT gaozhiwei timosaponinaiiiinducesg2marrestandapoptosisinbreastcancerbyactivatingtheatmchk2andp38mapksignalingpathways AT qiqi timosaponinaiiiinducesg2marrestandapoptosisinbreastcancerbyactivatingtheatmchk2andp38mapksignalingpathways AT yinhong timosaponinaiiiinducesg2marrestandapoptosisinbreastcancerbyactivatingtheatmchk2andp38mapksignalingpathways AT zhuling timosaponinaiiiinducesg2marrestandapoptosisinbreastcancerbyactivatingtheatmchk2andp38mapksignalingpathways AT wuyichen timosaponinaiiiinducesg2marrestandapoptosisinbreastcancerbyactivatingtheatmchk2andp38mapksignalingpathways AT liuwei timosaponinaiiiinducesg2marrestandapoptosisinbreastcancerbyactivatingtheatmchk2andp38mapksignalingpathways AT yangjian timosaponinaiiiinducesg2marrestandapoptosisinbreastcancerbyactivatingtheatmchk2andp38mapksignalingpathways AT huangxuefeng timosaponinaiiiinducesg2marrestandapoptosisinbreastcancerbyactivatingtheatmchk2andp38mapksignalingpathways |